Rapid screening of tissue microarrays for Her-2 fluorescence in situ hybridization testing is an accurate, efficient and economic method of providing an entirely in situ hybridization-based Her-2 testing service

Dana Faratian, Ashley Graham, Frances Rae, Jeremy Thomas

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Fluorescence in situ hybridization (FISH) testing is the 'gold standard' method for Her-2 status assessment in breast cancer patients, yet is only employed in about 30% of tests carried out because of cost and labour considerations. We have previously described tissue microarray (TMA)-based testing to eliminate cost constraints, and now describe a rapid screening approach to reduce time spent testing.
Original languageEnglish
Pages (from-to)428-32
Number of pages5
JournalHistopathology
Volume54
Issue number4
DOIs
Publication statusPublished - 2009

Fingerprint

Dive into the research topics of 'Rapid screening of tissue microarrays for Her-2 fluorescence in situ hybridization testing is an accurate, efficient and economic method of providing an entirely in situ hybridization-based Her-2 testing service'. Together they form a unique fingerprint.

Cite this